FLU AVERT® I.N.
Equine Influenza Vaccine
Product Description
An effective intranasal vaccine for equine influenza virus.
- Just one dose required for primary immunization or for a booster immunization following any other equine influenza virus (EIV) vaccine
- Proven safe and effective even in horses immunosuppressed by long-distance transport or exercise1
- Recommended for use during EIV outbreaks2
- When the vaccine replicates in the horse’s nasal mucosa, a rapid local immune response occurs. The horse develops an immune response that combats disease similar to when the horse is exposed to a virulent (disease-causing) wild strain of the equine influenza virus.
- This vaccine is a lyophilized preparation containing an attenuated, cold-adapted, viable equine influenza virus type H3N8 strain (EIV A/Equine 2/Kentucky/91). Contains no preservatives.
Indications
This product has been shown to be effective for the vaccination of healthy horses 11 months of age or older against disease caused by EIV. Duration of immunity has been shown to be at least 6 months. For more information regarding safety and efficacy data, go to productdata.aphis.usda.gov.
This product has been shown to be effective against virus shedding of EIV.
ADMINISTRATION
Dosage
Administer a single 1 mL dose intranasally in one nostril. The dose is administered into the nasal passages with a special proprietary applicator attached to a luer lock syringe. For more information on revaccination frequency, consult your veterinarian.
PRECAUTIONS
Cautions
Store at 2°-8°C (35°-46°F). Store out of direct sunlight. Do not vaccinate pregnant animals. Do not vaccinate within 21 days before slaughter. Do not mix with other products, except as specified on the label. Inactivate unused contents before disposal. If allergic reaction occurs, treat with epinephrine. We recommend that the vaccine be administered by a veterinarian or a trained technician. A small number of horses may experience mild post-vaccination side effects including slight nasal discharge. These signs should clear in a few days without additional treatment. In case of human exposure, contact a physician.
FOR ANIMAL USE ONLY
Resources
Learn more about the updated line of PRESTIGE vaccines.
Find PDFs to download on technical, bulletins, product updates, vaccinations, programs, outbreaks and other useful information.
Additional ResourcesReferences
- Lunn DP, Steve Hussey S, et al. Safety, efficacy, and immunogenicity of a modified-live equine influenza virus vaccine in ponies after induction of exercise-induced immunosuppression. JAVMA. 2001:218(6):900-906.
- AAEP Vaccination Guidelines available at www.aaep.org.
Go To United States
Algeria
Argentina
Australia
Austria
Bahrain
Belgium (Dutch)
Brazil
Canada (English)
Chile
Colombia
Croatia
Czech Republic
Denmark
Ecuador
Egypt
Finland
France
Germany
Greece
Hungary
India
Indonesia
Iraq
Ireland
Israel
Italy
Japan
Jordan
Kuwait
Lebanon
Malaysia
Mexico
Morocco
Netherlands
New Zealand
Norway
Oman
Panama
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Saudi Arabia
South Africa
South Korea
Spain
Sweden
Switzerland (French)
Taiwan
Thailand
Tunisia
Turkey
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Yemen
Global